Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 3 (2006), Issue 3 (March)

1. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.
   J Natl Cancer Inst, 98(5): 335-44. [Abstract] [Full-text]
2. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study.
   BMC Health Serv Res, 6: 8. [Abstract] [Full-text]
3. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.
   Pediatrics, 117(3): 626-32. [Abstract] [Full-text]
4. Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort.
   Pediatrics, 117(3): e528-36. [Abstract] [Full-text]
5. Long-term study of intraocular pressure changes in patients with human immunodeficiency virus treated with highly active antiretroviral therapy.
   Ophthalmology, 113(3): 451-5. [Abstract] [Full-text]
6. Patient-reported behavior and problems in using glaucoma medications.
   Ophthalmology, 113(3): 431-6. [Abstract] [Full-text]
7. Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures.
   Am J Cardiol, 97(6): 891-3. [Abstract] [Full-text]
8. Photodynamic therapy for urological malignancies: past to current approaches.
   J Urol, 175(4): 1201-7. [Abstract] [Full-text]
9. Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.
   Int J Cancer, 118(10): 2636-8. [Abstract] [Full-text]
10. Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
    Eur J Haematol, 76(4): 273-7. [Abstract] [Full-text]
11. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    JAMA, 295(10): 1142-6. [Abstract] [Full-text]
12. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
    Br J Cancer, 94(5): 625-30. [Abstract] [Full-text]
13. Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
    N Engl J Med, 354(10): 1021-30. [Abstract] [Full-text]
14. Cocaine self-administration in mice is inversely related to phosphorylation at Thr34 (protein kinase A site) and Ser130 (kinase CK1 site) of DARPP-32.
    J Neurosci, 26(10): 2645-51. [Abstract] [Full-text]
15. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
    Lancet, 367(9513): 825-31. [Abstract] [Full-text]
16. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
    Lancet, 367(9513): 817-24. [Abstract] [Full-text]
17. Better quality of life with neuropsychological improvement on HAART.
    Health Qual Life Outcomes, 4: 11. [Abstract] [Full-text]
18. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Pediatr Blood Cancer, 46(5): 630-6. [Abstract] [Full-text]
19. Racial disparities in access after regulatory surveillance of benzodiazepines.
    Arch Intern Med, 166(5): 572-9. [Abstract] [Full-text]
20. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Arch Intern Med, 166(5): 565-71. [Abstract] [Full-text]
21. Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells.
    Biochem Biophys Res Commun, 342(4): 1405-12. [Abstract] [Full-text]
22. Impact of a scientific presentation on community treatment patterns for primary breast cancer.
    J Natl Cancer Inst, 98(6): 382-8. [Abstract] [Full-text]
23. Antegrade scrotal sclerotherapy for treating primary varicocele in children.
    BJU Int, 97(4): 809-12. [Abstract] [Full-text]
24. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a.
    J Med Chem, 49(6): 1874-81. [Abstract] [Full-text]
25. Antimicrobial prophylaxis in clean surgery with special focus on inguinal hernia repair with mesh.
    J Hosp Infect, 62(4): 427-36. [Abstract] [Full-text]
26. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Biomaterials, 27(18): 3482-90. [Abstract] [Full-text]
27. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
    J Clin Oncol, 24(9): 1443-8. [Abstract] [Full-text]
28. Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
    J Clin Oncol, 24(9): 1428-34. [Abstract] [Full-text]
29. Complementary and alternative medicines versus prescription drugs: perceptions of emergency department patients.
    Emerg Med J, 23(4): 266-8. [Abstract] [Full-text]
30. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    J Clin Oncol, 24(9): 1395-403. [Abstract] [Full-text]
31. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
    J Clin Oncol, 24(9): 1435-42. [Abstract] [Full-text]
32. Comparison of computer integrated patient controlled epidural analgesia vs. conventional patient controlled epidural analgesia for pain relief in labour.
    Anaesthesia, 61(4): 339-44. [Abstract] [Full-text]
33. Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer.
    Int J Cancer, 118(11): 2790-5. [Abstract] [Full-text]
34. Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy.
    Int J Cancer, 118(11): 2877-81. [Abstract] [Full-text]
35. The role of anesthesiologists in the selection and administration of perioperative antibiotics: a survey of the American Association of Clinical Directors.
    Anesth Analg, 102(4): 1177-82. [Abstract] [Full-text]
36. Infusion pump delivers over-dosage of propofol as a result of missing syringe support.
    Anesth Analg, 102(4): 1154-6. [Abstract] [Full-text]
37. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume.
    Anesth Analg, 102(4): 1147-53. [Abstract] [Full-text]
38. Accidental epidural administration of succinylcholine.
    Anesth Analg, 102(4): 1139-40. [Abstract] [Full-text]
39. Giving toys to children reduces their anxiety about receiving premedication for surgery.
    Anesth Analg, 102(4): 1070-2. [Abstract] [Full-text]
40. A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
    Br J Cancer, 94(6): 806-13. [Abstract] [Full-text]
41. FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
    Br J Cancer, 94(6): 798-805. [Abstract] [Full-text]
42. Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial.
    Br J Cancer, 94(6): 792-7. [Abstract] [Full-text]
43. Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.
    Br J Cancer, 94(6): 785-91. [Abstract] [Full-text]
44. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Am J Epidemiol, 163(7): 589-99. [Abstract] [Full-text]
45. The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases.
    Am J Epidemiol, 163(7): 676-83. [Abstract] [Full-text]
46. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
    Am J Epidemiol, 163(7): 600-7. [Abstract] [Full-text]
47. Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers.
    Carcinogenesis, 27(4): 782-90. [Abstract] [Full-text]
48. The effect of axial length on photodynamic therapy.
    Am J Ophthalmol, 141(4): 699-702. [Abstract] [Full-text]
49. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Am J Ophthalmol, 141(4): 638-45. [Abstract] [Full-text]
50. Perceptions of the influence of prescription medicine samples on prescribing by family physicians.
    Med Care, 44(4): 383-7. [Abstract] [Full-text]
51. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.
    Invest Ophthalmol Vis Sci, 47(4): 1416-25. [Abstract] [Full-text]
52. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
    Am J Cardiol, 97(7): 1076-81. [Abstract] [Full-text]
53. Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.
    Am J Cardiol, 97(7): 1064-7. [Abstract] [Full-text]
54. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy.
    J Surg Oncol, 93(5): 422-8. [Abstract] [Full-text]
55. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
    J Surg Oncol, 93(5): 401-9. [Abstract] [Full-text]
56. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
    J Surg Oncol, 93(5): 387-93. [Abstract] [Full-text]
57. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy.
    Sex Transm Dis, 33(4): 250-5. [Abstract] [Full-text]
58. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
    Cancer, 106(7): 1560-8. [Abstract] [Full-text]
59. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Cancer, 106(7): 1569-80. [Abstract] [Full-text]
60. Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma.
    Cancer, 106(7): 1498-506. [Abstract] [Full-text]
61. Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.
    Leuk Res, 30(6): 681-5. [Abstract] [Full-text]
62. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial.
    Am Heart J, 151(4): 798.e1-7. [Abstract] [Full-text]
63. Rescue percutaneous coronary intervention after failed fibrinolytic therapy: have expectations been met?
    Am Heart J, 151(4): 779-85. [Abstract] [Full-text]
64. Water-soluble bis(imidazolylporphyrin) self-assemblies with large two-photon absorption cross sections as potential agents for photodynamic therapy.
    J Med Chem, 49(7): 2276-83. [Abstract] [Full-text]
65. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
    J Clin Oncol, 24(10): 1590-6. [Abstract] [Full-text]
66. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
    J Clin Oncol, 24(10): 1582-9. [Abstract] [Full-text]
67. Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
    J Clin Oncol, 24(10): 1575-81. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.